Different expression systems for production of recombinant proteins in Saccharomyces cerevisiae

Biotechnology and Bioengineering

Volumn 109, Issue 5, 2012, Pages 1259-1268

  Liu, Zihe ^a   Tyo, Keith E J ^a   Martínez, José L ^a   Petranovic, Dina ^a   Nielsen, Jens ^a,b  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b Northwestern University   (United States)

Author keywords

amylase; Expression systems; Insulin precursor; Leader sequence; Saccharomyces cerevisiae; Secretory pathway

Indexed keywords

BATCH FERMENTATION; DIAUXIC SHIFT; EXPRESSION SYSTEM; EXPRESSION SYSTEMS; EXPRESSION VECTORS; GENES CODING; GLUCOSE UPTAKE; GLYCOSYLATED; INDUSTRIAL ENZYMES; LEADER SEQUENCE; MARKER GENES; MULTI DOMAINS; PHARMACEUTICAL PROTEIN; PROTEIN PRODUCTION; RECOMBINANT PROTEIN PRODUCTIONS; RECOMBINANT PROTEIN SECRETION; SECRETORY PATHWAYS; SPECIALITY CHEMICALS; VECTOR SYSTEMS; YEAST SACCHAROMYCES CEREVISIAE;

AMYLASES; DNA; ETHANOL; GENE EXPRESSION; GLUCOSE; INDUSTRIAL CHEMICALS; INSULIN; RECOMBINANT PROTEINS; VECTORS;

YEAST;

ALCOHOL; AMYLASE; GLUCOSE; PLASMID VECTOR; PREPROINSULIN; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BATCH FERMENTATION; CONTROLLED STUDY; EXPRESSION VECTOR; FUNGAL STRAIN; GLUCOSE TRANSPORT; GLYCOSYLATION; KINETICS; MARKER GENE; NONHUMAN; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECRETION; SACCHAROMYCES CEREVISIAE;

ALPHA-AMYLASES; BIOTECHNOLOGY; GENE EXPRESSION; GENETIC VECTORS; INSULIN; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEIN ENGINEERING; PROTEIN SORTING SIGNALS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES CEREVISIAE;

EID: 84862807811     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24409     Document Type: Article

References (59)

1. Achstetter T, Wolf D. 1985. Hormone processing and membrane-bound proteinases in yeast. EMBO J 4(1): 173-177.
2. Agaphonov M, Romanova N, Choi E, Ter-Avanesyan M. 2010. A novel kanamycin/G418 resistance marker for direct selection of transformants in Escherichia coli and different yeast species. Yeast 27(4): 189-195.
3. Aggarwal S. 2010. What's fueling the biotech engine-2009-2010. Nat Biotechnol 28(11): 1165-1171.
4. Alao J, Olesch J, Sunnerhagen P. 2009. Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay. Mol Cancer Ther 8(9): 2606-2615.
5. Alexandre H, Ansanay-Galeote V, Dequin S, Blondin B. 2001. Global gene expression during short-term ethanol stress in Saccharomyces cerevisiae. FEBS Lett 498(1): 98-103.
6. Berretta J, Pinskaya M, Morillon A. 2008. A cryptic unstable transcript mediates transcriptional trans-silencing of the Ty1 retrotransposon in S. cerevisiae. Genes Dev 22(5): 615-626.
7. Bulavaite A, Sabaliauskaite R, Staniulis J, Sasnauskas K. 2006. Synthesis of hepatitis B virus surface protein derivates in yeast S. cerevisiae. Biologija 4: 49-53.
8. Butz JA, Niebauer RT, Robinson AS. 2003. Co-expression of molecular chaperones does not improve the heterologous expression of mammalian G-protein coupled receptor expression in yeast. Biotechnol Bioeng 84(3): 292-304.
9. Carlsen M, Jochumsen KV, Emborg C, Nielsen J. 1997. Modeling the growth and proteinase A production in continuous cultures of recombinant Saccharomyces cerevisiae. Biotechnol Bioeng 55(2): 447-454.
10. Chigira Y, Oka T, Okajima T, Jigami Y. 2008. Engineering of a mammalian O-glycosylation pathway in the yeast Saccharomyces cerevisiae: Production of O-fucosylated epidermal growth factor domains. Glycobiology 18(4): 303-314.
11. Compagno C, Brambilla L, Capitanio D, Boschi F, Maria Ranzi B, Porro D. 2001. Alterations of the glucose metabolism in a triose phosphate isomerase-negative Saccharomyces cerevisiae mutant. Yeast 18(7): 663-670.
12. Corrales-Garcia L, Possani L, Corzo G. 2011. Expression systems of human β-defensins: Vectors, purification and biological activities. Amino Acids 40(1): 5-13.
13. Egel-Mitani M, Andersen AS, Diers I, Hach M, Thim L, Hastrup S, Vad K. 2000. Yield improvement of heterologous peptides expressed in yps1-disrupted Saccharomyces cerevisiae strains. Enzyme Microb Technol 26(9-10): 671-677.
14. Fama MC, Raden D, Zacchi N, Lemos DR, Robinson AS, Silberstein S. 2007. The Saccharomyces cerevisiae YFR041C/ERJ5 gene encoding a type I membrane protein with a J domain is required to preserve the folding capacity of the endoplasmic reticulum. Biochim Biophys Acta 1773(2): 232-242.
15. Fischer C, Alper H, Nevoigt E, Jensen K, Stephanopoulos G. 2006. Response to Hammer et al.: Tuning genetic control-Importance of thorough promoter characterization versus generating promoter diversity. Trends Biotechnol 24(2): 55-56.
16. Fujikawa K, Chung D, Hendrickson L, Davie E. 1986. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 25(9): 2417-2424.
17. Gabrielsen O, Reppe S, Sther O, Blingsmo O, Sletten K, Gordeladze J, Hgset A, Gautvik V, Alestrm P, Yen T. 1990. Efficient secretion of human parathyroid hormone by Saccharomyces cerevisiae. Gene 90(2): 255-262.
18. Hackel BJ, Huang D, Bubolz JC, Wang XX, Shusta EV. 2006. Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae. Pharm Res 23(4): 790-797.
19. Hahn-Hägerdal B, Karhumaa K, Fonseca C, Spencer-Martins I, Gorwa-Grauslund M. 2007. Towards industrial pentose-fermenting yeast strains. Appl Microbiol Biotechnol 74(5): 937-953.
20. Harmsen MM, Bruyne MI, Rau HA, Maat J. 1996. Overexpression of binding protein and disruption of the PMR1 gene synergistically stimulate secretion of bovine prochymosin but not plant thaumatin in yeast. Appl Microbiol Biotechnol 46(4): 365-370.
21. Homma T, Iwahashi H, Komatsu Y. 2003. Yeast gene expression during growth at low temperature. Cryobiology 46(3): 230-237.
22. Kawasaki G. 1999. Stable DNA constructs. Patent Application 005871957A.
23. Kim YS, Bhandari R, Cochran JR, Kuriyan J, Wittrup KD. 2006. Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast. Proteins 62(4): 1026-1035.
24. Kjeldsen T, Brandt J, Andersen AS, Egel-Mitani M, Hach M, Pettersson AF, Vad K. 1996. A removable spacer peptide in an α-factor-leader/insulin precursor fusion protein improves processing and concomitant yield of the insulin precursor in Saccharomyces cerevisiae. Gene 170(1): 107-112.
25. Kjeldsen T, Hach M, Balschmidt P, Havelund S, Pettersson A, Markussen J. 1998a. Prepro-leaders lacking N-linked glycosylation for secretory expression in the yeast Saccharomyces cerevisiae. Protein Expression Purif 14(3): 309-316.
26. Kjeldsen T, Pettersson AF, Drube L, Kurtzhals P, Jonassen I, Havelund S, Hansen PH, Markussen J. 1998b. Secretory expression of human albumin domains in Saccharomyces cerevisiae and their binding of myristic acid and an acylated insulin analogue. Protein Expression Purif 13(2): 163-169.
27. Kjeldsen T, Frost Pettersson A, Hach M. 1999. The role of leaders in intracellular transport and secretion of the insulin precursor in the yeast Saccharomyces cerevisiae. J Biotechnol 75(2-3): 195-208.
28. Kjeldsen T, Ludvigsen S, Diers I, Balschmidt P, Sorensen AR, Kaarsholm NC. 2002. Engineering-enhanced protein secretory expression in yeast with application to insulin. J Biol Chem 277(21): 18245-18248.
29. Kuroda K, Matsui K, Higuchi S, Kotaka A, Sahara H, Hata Y, Ueda M. 2009. Enhancement of display efficiency in yeast display system by vector engineering and gene disruption. Appl Microbiol Biotechnol 82(4): 713-719.
30. Li J, Xu H, Bentley WE, Rao G. 2002. Impediments to secretion of green fluorescent protein and its fusion from Saccharomyces cerevisiae. Biotechnol Prog 18(4): 831-838.
31. Nguyen VD, Saaranen MJ, Karala A-R, Lappi A-K, Wang L, Raykhel IB, Alanen HI, Salo KEH, Wang C-C, Ruddock LW. 2011. Two endoplasmic reticulum PDI peroxidases increase the efficiency of the use of peroxide during disulfide bond formation. J Mol Biol 406(3): 503-515.
32. Partow S, Siewers V, Bjrn S, Nielsen J, Maury J. 2010. Characterization of different promoters for designing a new expression vector in Saccharomyces cerevisiae. Yeast 27(11): 955-964.
33. Payne T, Finnis C, Evans LR, Mead DJ, Avery SV, Archer DB, Sleep D. 2008. Modulation of chaperone gene expression in mutagenised S. cerevisiae strains developed for rHA production results in increased production of multiple heterologous proteins. Appl Environ Microbiol 74(24): 7759-7766.
34. Piper P. 1995. The heat shock and ethanol stress responses of yeast exhibit extensive similarity and functional overlap. FEMS Microbiol Lett 134(2-3): 121-127.
35. Porro D, Sauer M, Branduardi P, Mattanovich D. 2005. Recombinant protein production in yeasts. Mol Biotechnol 31(3): 245-259.
36. Rakestraw A, Wittrup KD. 2006. Contrasting secretory processing of simultaneously expressed heterologous proteins in Saccharomyces cerevisiae. Biotechnol Bioeng 93(5): 896-905.
37. Rakestraw JA, Sazinsky SL, Piatesi A, Antipov E, Wittrup KD. 2009. Directed evolution of a secretory leader for the improved expression of heterologous proteins and full-length antibodies in S. cerevisiae. Biotechnol Bioeng 103(6): 1192-1201.
38. Randez-Gil F, Sanz P. 1993. Expression of Aspergillus oryzae α-amylase gene in Saccharomyces cerevisiae. FEMS Microbiol Lett 112(1): 119-124.
39. Robinson AS, Hines V, Wittrup KD. 1994. Protein disulfide isomerase overexpression increases secretion of foreign proteins in Saccharomyces cerevisiae. Nat Biotechnol 12(4): 381-384.
40. Robinson AS, Bockhaus JA, Voegler AC, Wittrup KD. 1996. Reduction of BiP levels decreases heterologous protein secretion in Saccharomyces cerevisiae. J Biol Chem 271(17): 10017-10022.
41. Romanos MA, Makoff AJ, Fairweather NF, Beesley KM, Slater DE, Rayment FB, Payne MM, Clare JJ. 1991. Expression of tetanus toxin fragment C in yeast: Gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA. Nucleic Acids Res 19(7): 1461-1467.
42. Schmidt F. 2004. Recombinant expression systems in the pharmaceutical industry. Appl Microbiol Biotechnol 65(4): 363-372.
43. Sidorenko Y, Antoniukas L, Schulze-Horsel J, Kremling A, Reichl U. 2008. Mathematical model of growth and heterologous hantavirus protein production of the recombinant yeast Saccharomyces cerevisiae. Eng Life Sci 8(4): 399-414.
44. Smith JD, Robinson AS. 2002. Overexpression of an archaeal protein in yeast: Secretion bottleneck at the ER. Biotechnol Bioeng 79(7): 713-723.
45. Smith JD, Tang BC, Robinson AS. 2004. Protein disulfide isomerase, but not binding protein, overexpression enhances secretion of a non-disulfide-bonded protein in yeast. Biotechnol Bioeng 85(3): 340-350.
46. Srivastava A, Piskur J, Nielsen J, Egel-Mitani M. 2001. Method for the production of heterologous polypeptides in transformed yeast cells. patent US 6, 90, 883 B1.
47. Stagoj MN, Comino A, Komel R. 2006. A novel GAL recombinant yeast strain for enhanced protein production. Biomol Eng 23(4): 195-199.
48. Toikkanen JH, Sundqvist L, Keranen S. 2004. Kluyveromyces lactis SSO1 and SEB1 genes are functional in Saccharomyces cerevisiae and enhance production of secreted proteins when overexpressed. Yeast 21: 1045-1055.
49. Tu B, Ho-Schleyer S, Travers K, Weissman J. 2000. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science 290(5496): 1571-1574.
50. Tutar L, Tutar Y. 2010. Heat shock proteins; an overview. Curr Pharm Biotechnol 11(2): 216-222.
51. Tyo K, Liu Z, Petranovic D, Nielsen J. Submitted. Balance in endoplasmid reticulum folding and oxidation rates key to mitigating secretory stress. BMC Syst Biol.
52. Van de Laar T, Visser C, Holster M, López C, Kreuning D, Sierkstra L, Lindner N, Verrips T. 2007. Increased heterologous protein production by Saccharomyces cerevisiae growing on ethanol as sole carbon source. Biotechnol Bioeng 96(3): 483-494.
53. Visser D, van Zuylen G, van Dam J, Eman M, Prll A, Ras C, Wu L, van Gulik W, Heijnen J. 2004. Analysis of in vivo kinetics of glycolysis in aerobic Saccharomyces cerevisiae by application of glucose and ethanol pulses. Biotechnol Bioeng 88(2): 157-167.
54. Walsh G. 2010. Biopharmaceutical benchmarks 2010. Nat Biotechnol 28(9): 917-924.
55. Werner R. 2004. Economic aspects of commercial manufacture of biopharmaceuticals. J Biotechnol 113(1-3): 171-182.
56. Wittrup K, Robinson A, Parekh R, Forrester K. 1994. Existence of an optimum expression level for secretion of foreign proteins in yeast. Ann N Y Acad Sci 745(1): 321-330.
57. Xu P, Raden D, Doyle FJ, Robinson AS. 2005. Analysis of unfolded protein response during single-chain antibody expression in Saccaromyces cerevisiae reveals different roles for BiP and PDI in folding. Metab Eng 7(4): 269-279.
58. Zhang B, Chang A, Kjeldsen TB, Arvan P. 2001. Intracellular retention of newly synthesized insulin in yeast is caused by endoproteolytic processing in the golgi complex. J Cell Biol 153(6): 1187-1198.
59. Zhang B, Liu M, Arvan P. 2003. Behavior in the eukaryotic secretory pathway of insulin-containing fusion proteins and single-chain insulins bearing various B-chain mutations. J Biol Chem 278(6): 3687-3693.